Tarsus Pharmaceuticals, Inc.
USD61.26
-1.66 (-2.64%)
CEO
Bobak R. Azamian
IPO Date
2020-10-16
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$62.85
Prev. Close
$62.92
Day Low
$60.76
Day High
$62.85
52W Low
$38.51
52W High
$85.25
Market Cap
$2.64B
Volume
0.96M
| -18.0 |
| 31 Dec 2023 | FY | 90.9% | -778.9% | -69.0% | -51.2% | 0.15 | 6.93 | -4.4 |
| 31 Dec 2022 | FY | 96.3% | -240.5% | -32.2% | -27.2% | 0.10 | 14.61 | -5.8 |
| 31 Dec 2021 | FY | 96.4% | -24.2% | -8.3% | -7.7% | 0.01 | 15.33 | -33.4 |
| 31 Dec 2020 | FY | 0.0% | 0.0% | -16.2% | -15.6% | 0.01 | 31.68 | -31.3 |
| 31 Dec 2019 | FY | 0.0% | 0.0% | 77.8% | -8.0% | -0.03 | 70.85 | -86.0 |
| 31 Dec 2018 | FY | 0.0% | 0.0% | 97.4% | -55.2% | 0.00 | 13.31 | -66.9 |
| -104.6 |
| 30 Sept 2025 | Q3 | 79.3% | -10.6% | -3.8% | -2.4% | 0.25 | 4.29 | -50.3 |
| 30 Jun 2025 | Q2 | 93.9% | -19.8% | -6.1% | -4.1% | 0.22 | 5.26 | -21.1 |
| 31 Mar 2025 | Q1 | 93.3% | -32.1% | -7.3% | -5.0% | 0.21 | 5.57 | -20.1 |
| 31 Dec 2024 | Q4 | 92.6% | -34.8% | -10.3% | -6.1% | 0.32 | 4.42 | -23.1 |
| 30 Sept 2024 | Q3 | 93.3% | -48.7% | -9.9% | -6.2% | 0.30 | 5.42 | -13.5 |
| 30 Jun 2024 | Q2 | 92.6% | -81.6% | -13.2% | -8.8% | 0.29 | 7.03 | -8.0 |
| 31 Mar 2024 | Q1 | 94.0% | -129.4% | -13.0% | -10.2% | 0.11 | 8.01 | -8.9 |
| 31 Dec 2023 | Q4 | 90.7% | -320.4% | -21.3% | -15.8% | 0.15 | 6.93 | -3.9 |